Article
A novel microRNA signature for the detection of melanoma by liquid biopsy
15 Oct 2022
Abstract excerpt
BACKGROUND: Melanoma is the deadliest form of skin cancer and metastatic disease is associated with a significant survival rate drop. There is an urgent need for consistent tumor biomarkers to scale precision medicine and reduce cancer mortality. Here, we aimed to identify a melanoma-specific circulating microRNA signature and assess its value as a diagnostic tool. METHODS: The study consisted of a discovery...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
